Form 4 for NXL Nexalin Technology, Inc.
Accepted 2024-10-30 00:00:00 ET · period of report 2024-10-28 · accession 0001829126-24-007091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-30 | 2024-10-28 | NXL | Owens David | Chief Medical Off, Dir | P - Purchase | $2.19 | +500 | 148.3K | +0.3% | +$1,095 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-10-28 | P | A | 500 | $2.19 | 148,293 | D | — | — |